Selected Research Papers
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
National Library of Medicine June 2017
Effects of Cannabidiol
Cannabinoids in the management of difficult to treat pain
National Library of Medicine Feb 2008
CBD can ease and manage pain
Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis
Journal of Pharmacology and Experimental Therapeutics, June 2018
CBD tamps down the immune system’s overreaction in the skin when someone comes in contact with an allergen.
US FDA Approves GW Pharmaceuticals' Epidolex to Treat Epilepsy
NEJM, May 2017
It was recently approved by the FDA as an epilepsy medicine for children.
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
Neuroscience & Biobehavioral Reviews, January 2017
CBD improves cognitive function in people with neurodegenerative diseases but doesn’t affect cognition in healthy people.
Inhibition of cervical cancer cell proliferation by cannabidiol
Planta Medica, December 14, 2016
CBD is a potential treatment for cervical cancer.
Cannabidiol, neuroprotection and neuropsychiatric disorders
Pharmacological Research, October 2016
CBD reduces brain damage from diseases, and promotes brain cell growth and brain “plasticity”.
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
European Journal of Pain, July 2016
CBD is a potential topical treatment for arthritis pain.
Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors
Behavioural Brain Research, January 20, 2016
CBD is a potential antidepressant.
Cannabidiol as a Potential Treatment for Anxiety Disorders
Neurotherapeutics, October 2015
CBD can be used to treat generalized anxiety disorder, panic disorder, social anxiety disorder, obsessive–compulsive disorder, and post-traumatic stress disorder.
A systematic review of the antipsychotic properties of cannabidiol in humans
Schizophrenia Research, March 2015
CBD is a promising treatment for schizophrenia.
Cannabidiol, a Major Non‐Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts
Wiley Online Publishing, March 2015
CBD enhances fracture healing.
Overcoming the Bell‐Shaped Dose‐Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol
Scientific Research Publishing, Feburary 2015
CBD can be used to relieve anxiety and inflammation without the psychotropic effect.
Cannabis, a complex plant: different compounds and different effects on individuals
NCBI, December 2012
There are over 60 different cannabinoid compounds found in the cannabis plant.